Docket Room
A 4924·NJ·house

Establishes "End-Stage Kidney Disease Prevention and Innovation Act"; appropriates $10 million.

In CommitteeFiled May 7, 2026
Sponsor: Stewart, Kenyatta
Latest Action

Introduced First Reading Assembly Referred to AHE

May 7, 2026

Summary

The bill orders the New Jersey Department of Health to establish Centers on Rare Kidney Disease Research and to award grants and cooperative agreements to nonprofit partners. It focuses on patients with rare kidney conditions, especially in underserved and minority communities, by funding research, public awareness, and training for health providers. Up to $10 million from the General Fund will support these activities, and the program will run for five years.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when A 4924 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice